These investments support and fund cross-discipline research activities that will address the biological, medical, social and economic aspects of addiction and substance misuse.
The aim of this programme is to support and fund research that examines how mental health problems emerge in young people, what makes some more susceptible or resilient than others, and how we can intervene early to promote positive mental health and wellbeing.
The aim of this area of investment is to fund innovative applied research to improve adolescent health in low and middle-income countries (LMICs).
The aim of this programme is to deliver a consortium-based platform of national scale that will break through the complexity of pain and reveal potential new treatment approaches to address a wide spectrum of chronic and debilitating clinical conditions.
The aim of this programme is to support and enable UK researchers to carry out unique research, in collaboration with colleagues around the world, to improve our understanding of antimicrobial resistance.
MRC supports and funds research into autism, focusing on early life stages and on the potential for early intervention.
The aim of Better Methods, Better Research is to ensure optimal research methods are being used to advance biomedical, health and care focused research, policy and delivery. Funding is available for research that develops and delivers ways to improve the research methods being used by others.
The aim of this investment area is to harness, with public trust, the power of data resources and tools to gain new health and wellbeing insights. This will enable biomedical and health research on a scale not previously possible, leading to transformational advances in medicine and public health.
The aim of this programme is to improve understanding of the pathways between climate, environment and health so that we can better protect and promote human health and wellbeing in the face of climate challenges.
The aim of MRC’s clinical and translational research is to support and fund innovation that will speed up the transfer of the best ideas from discovery research into new interventions that reach patients, and improve the return on investment in fundamental research.